Relyvrio

Business

Amylyx stock gains as it pulls ALS therapy Relyvrio

chrupka/iStock via Getty Images Amylyx Pharmaceuticals (NASDAQ:AMLX) on Thursday formally announced its decision to withdraw Relyvrio, an FDA-approved therapy for…

Read More »
Back to top button